curriculum vitae · selected to represent cpnp at the eunice kennedy shriver national institute of...
TRANSCRIPT
1
CURRICULUM VITAE
Julie Ann Dopheide
PERSONAL INFORMATION
Business Address
University of Southern California
School of Pharmacy
1985 Zonal Avenue
Los Angeles, California 90089
Business Telephone (323) 226-5540 - Clinic office
(323) 442-1454 - Voice mail
(323) 442-1681 - Facsimile
Cell (818) 749-4999 - mobile
(310) 668-3098 - LAC+USC -Hawkins
Email Address [email protected]
Home Address 724 Groton Drive
Burbank, CA 91504
Home Telephone 818-238-0050
Place of Birth Omaha, Nebraska
Citizenship United States of America
Pharmacy Licensure California 41936, 1988
Nebraska 10188, 1988 (inactive)
Specialty Certification Board Certification in Psychiatric Pharmacy
(BCPP 496223), conferred December 1996
Joint Appointment USC’s Keck School of Medicine's
Department of Psychiatry and the
Behavioral Sciences,
conferred July 1998
2
EDUCATION AND TRAINING
March 2008 National Alliance for the Mentally Ill “Family to Family” Course
NAMI San Gabriel Valley Chapter
Pasadena, California
December 1997 Residency Learning System (RLS) Training Module
ASHP Midyear Clinical Meeting
Atlanta, Georgia
June 1994 Pharmacist's Patient Consultation Program (PPCP-1 & 2)
How to Counsel Patients in Challenging Situations
Facilitator's Training Program with Certification
Sponsored by University of Tennessee School of Pharmacy
and Pfizer Pharmaceuticals. D. Gourley, Pharm.D., Coordinator
1988-1989 University of Southern California School of Pharmacy
1985 Zonal Avenue, Los Angeles, California 90033
Psychopharmacy Resident and Lecturer in Clinical Pharmacy
Residency Coordinator - Michael Z. Wincor, Pharm.D.
1984-1988 University of Nebraska College of Pharmacy, Omaha, Nebraska
Doctor of Pharmacy
1982-1984 Kearney State College, Kearney, Nebraska
Pre-Pharmacy
PROFESSIONAL EXPERIENCE
2013 (Jan) Healthcare Manpower Development Expert (HMDP)
Ministry of Health – Singapore
Invited to assist in developing psychiatric pharmacy
residency program that would qualify for accreditation
within ASHP. Lectures provided throughout city on topics in
psychopharmacology. Attended child/adult ward rounds with pharmacists
to instruct them on integration into the multidisciplinary team
Participated in clozapine clinic and treatment refractory depression clinic
2008 – present Center for Community Health at JWCH at the Weingart
Supervise PGY-2 Psychiatric Pharmacy Resident in the
provision of ambulatory psychiatric services to adults
with comorbid medical illnesses. Bimonthly service/on-site
supervision. Weekly supervision off-site
3
2008 (October) Healthcare Manpower Development Expert (HMDP)
Ministry of Health – Singapore
Delivered 24 educational presentations, workshops and
seminars to pharmacists, physicians and allied health care
workers. Purpose to advance clinical pharmacy services in
mental health
1999 - present Associate Professor of Clinical Pharmacy, Psychiatry and
the Behavioral Sciences, University of Southern California
Schools of Pharmacy and Medicine
Monitoring medication regimens of psychiatric inpatients
(children, adolescents and adults)
Conducting weekly pharmacy medication education groups
for adult and youth inpatients, topics include:
Psychotropic drug information
Drug abuse education
HIV education/prevention
Family planning
Providing consultation to staff regarding drug therapy
Pharmacokinetic consultation for lithium, valproate, phenytoin
Providing in-service education to psychiatric treatment team
Adverse drug reaction reporting / documentation
Medication error reporting / documentation
Conducting discharge counseling with patients and students
Provided medication management for a caseload of
outpatients with psychiatric illness 1988 - 2000
1998 - 1999 Assistant Professor of Clinical Pharmacy, Psychiatry, and
the Behavioral Sciences, University of Southern California
Schools of Pharmacy and Medicine
1990 - 1998 Assistant Professor of Clinical Pharmacy
University of Southern California School of Pharmacy
Los Angeles, California
1989 - 1990 Clinical Instructor
University of Southern California School of Pharmacy
Los Angeles, California
TEACHING RECORD
Preceptor for fourth-level Pharm.D. students (21-25 per year)
Developed Medical/Pharmacy Student Case Presentations
Leading student teaching conferences, role-modeling the provision of
4
pharmaceutical care for inpatients with psychiatric illness
1990 - present
Co-coordinator, Therapeutics I Principles of Basic Sciences, Clinical
Therapeutics and Pharmacogenomics 2011 - present
Co-coordinator, ANS Module III - Therapeutics 1998 to 2004
Introduction, Sympathetic Storm, Cases (10 hours lecture)
Case conference development
Lectures in CNS Module IV - Therapeutics
Child and Adolescent Psychiatric Disorders: Clinical Characteristics
And Pharmacological Management (4 hours) 1991- present
Eating Disorders (2 hour) 1991 - present
Therapeutics of Headache and treatment (2 hours) 1998 - present
The Treatment of Major Depressive Disorders (3 hours)
1992-1995, 2001
Therapeutics of Bipolar Disorder (3 hours) 2001 to 2005
Schizophrenia and Antipsychotic Therapy (4hrs) 2002
Psychiatric Pharmacy Practice Elective (12 hours) - 1999
Women's Health Elective (3 hours) 1998 to 2003, 2006 - 2010
Lectures presented to Foreign Graduate Students:
Schizophrenia - Diagnosis and Treatment (2 hours)
1993-1995
Major Depressive Disorder - Diagnosis and Treatment (2 hours)
1993-1995
Conference leader for first level Pharm.D. candidates:
Communication Skills course team taught in six 6-week blocks
1996-1998
Conference leader for third level Pharm.D. candidates:
Professional Interactions course - Mental Status Exam
1994 -1998
Lecturer for California Pharmacy Board Preparatory Course
Review of Psychiatry and Psychopharmacology
2000 - present
Child/Adolescent Psychopharmacology
Therapeutics of Headache and Opioids
1999 to 2000
Lecturer for 1st and 2nd year Medical students at USC
Pharmacotherapy of Mood Disorders
1997 to present
Lecturer for first year Psychiatry and Psychiatric Pharmacy Residents
on Pharmacodynamics and Pharmacokinetics of the Psychotropics
1991 to present
Lecturer for 2nd
and 4th
year Psychiatry Residents on Child and Adolescent
Psychopharmacology
2005 to present
Lecturer to Psychology interns on Pediatric Psychopharmacology
1994 – present
5
1989-1990 Instructor of Clinical Pharmacy
University of Southern California School of Pharmacy,
1988 - 2012 Pharmacist Specialist, per diem
Kaiser Permanente Mental Health Center
765 North College Street
Los Angeles, California 90012
(213) 580-7355
Responsibilities include:
Prescribing medications to inpatients as needed
Inpatient drug dispensing and inventory control
Supervising unit-dose distribution
Outpatient medication dispensing
Providing drug information to staff
Obtaining patient drug histories
Medication education group for patients and families
Individual patient education
Inservice education to nursing students
PROFESSIONAL AND HONORARY SOCIETIES
College of Psychiatric and Neurologic Pharmacists (CPNP) - member since 1994
President (elected position) 2013-2014
President Elect (elected position) – 2012-2013
Strategic Planning Meeting - 2008, 2009, 2012, 2013
Secretary, Board Member (elected position) 2006 – 2008
Awards and Nominations Committee chair - 2003 to 2005
NAMI Relationship Management Group 2005 – 2008
Recertification committee member – 2006-2007
Recertification Review committee – 2007-2010
Residency & New Practitioner Committee member - 2006-present
Chair: 2007 – 2010 chair
Business Development Committee – Vice chair – 2009- 2010
Comprehensive Medication Management Reimbursement Task Force
2012- 2013
Government Affairs Committee – 2012 to present
College of Psychiatric and Neurologic Pharmacists Foundation Board member – 2009 - 2012
American Society of Hospital Pharmacists - member since 1987
Clinical Specialists Division- member since 1993 to present
Programming Committee since 1997 to 2003, Chair 2001- 2002
Meeting Program Associate for Midyear Clinical Meeting – ‘95, ‘98, ‘99, ‘02, ‘12
6
Psychiatry/Neurology Network Facilitator 1999 to 2000
Faculty for Board Exam Preparatory Course – 2000 - 2007
Psychiatric Residency Accreditation Site Reviewer – 2004, 2005, 2008, 2011
AJHP Editorial Board member (4 yr term) 2003 – 2007
Co-Author for Standards for PGY-2 Psychiatric Specialty Residency-2007
American Pharmaceutical Association Disease State Management Guideline
Development Panelist - 1996 to 1999
American Association of Colleges of Pharmacy - member since 1991
Delegate - 2000 – 2002
National Alliance for the Mentally Ill - member since 1999
National Mucopolysaccharidoses (MPS) Society – member since 2000
California Society of Hospital Pharmacists - member 1988-2008
Continuing Education Committee - 1994
UNIVERSITY AND PUBLIC SERVICE
Secretary, Pharmacy Faculty Council
USC School of Pharmacy
2012-2013
Interprofessional Education Task Force
Led joint pharmacy/medical student case conference
February 2012
Patient Safety and Clinical Pharmacy Collaborative (PSPC)
Liaison with CPNP to recommend outcome measures for psychiatric disorders
March-May 2011
Best Pharmaceuticals for Children Act Annual Meeting (BPCA) at NIH
Invited Panelist supported by Eunice Kennedy Shriver National Institute of
Child Health & Human Development
Representative from CPNP for Prioritization of Neurologic disorders in Youth
November 2010 – NIH – Rockville, MD
Best Pharmaceuticals for Children Act Annual Meeting (BPCA) at NIH
Invited Panelist supported by Eunice Kennedy Shriver National Institute of
Child Health & Human Development
Representative from CPNP to Task force on Antipsychotic Use in Youth
November 2009 – NIH – Bethesda, MD
NAMI Walk for the Mind of America
7
Organized fundraising team, “Brainpharmers” with students and pharmacists
October 2005, October 2007, October 2012
“Med Guide Response” author from the College of Psychiatric and Neurologic
Pharmacists, response sent to FDA during public hearings. May 2007
Queenscare Inpatient Grant Author/Coordinator
May 2006 to 2008
Psychiatric Pharmacy Practice Residency Program Director
July 1997 to present
Psychotropic Guidelines Committee (Pediatric Guideline Development)
Los Angeles County Department of Mental Health
March 2004 to present
Psychotropic Medication Authorization Review for Edelman Children's Court
December 2003 - 2005
University of Southern California Community Health Screening
October 2001, October 2003
ASP Patient Counseling Competition Judge
November 2000 through November 2004, December 2008
Psychiatric Pharmacotherapy Update Chairperson
1998 to 1999
National Anxiety Disorders Screening Day - May 1, 1996
Conducted screening at Thrifty/Payless Pharmacy in Beverly Hills, CA
Item Writer and Reviewer for Board Certification in Psychiatric Pharmacy
Practice Examination, 1996 to present
Committee Membership
University of Southern California, School of Pharmacy
Pharmacy Faculty Assembly
Secretary -2012
Executive Board – 2006 to 2007; 2012-2013
Clinical department representative 1995 -1998
Peer review Committee 2007 to 2010
Residency Council 2002 to present
8
Educational Programming Advisory Committee
1999 to 2002
USC Neighborhood Outreach Campaign Leader
1995-96
Intermodule Coordinating Council member (IMCC)
Committee Member, 1994 - present
Co-leader, Autonomic Module, Therapeutics III - 1997-2004
Course Coordinator Therapeutics I 2011 - present
Los Angeles County + USC Medical Center
Critical Pathway Development Team - Psychiatry
1997-1998
Joint Commission Task Force for Los Angeles County
Member - January 1995 to 1996, 1998 to present
Quality Assurance and Improvement Committee;
name changed in 2000 to Clinical Council
1993 - present
HONORS AND AWARDS
Awarded $40,000 grant from AMGEN to support a PGY-2
Psychiatric pharmacy resident 2010-2011
Selected to represent CPNP at the Eunice Kennedy Shriver
National Institute of Child Health and Human Development
National Institutes of Health
NICHD Joint Meeting of Child Health Clinical Research Priorities
and BPCA Annual Prioritization – 2009 and 2010 - ongoing
Hosted Visiting Scholar from Singapore
Clinical Psychiatric Pharmacy Training
November 2009 – November 2010
Appointed to Editorial Board of the American Journal of
Health-System Pharmacy, Fall 2003 for 4 year term
Invited to Participate in ADHD Educational website entitled:
Focusonadhd.com. (only pharmacist expert) 2003 to present
Faculty Appreciation Award
USC Pharmacy School Class of 2003
9
Professor of the Year Award
USC Pharmacy School Class of 2001
Preceptor of the Year Award
USC Pharmacy Residency Class of 2000
Research Paper of the Year Award, USC School of Pharmacy
presented at faculty meeting, April 2000
Pharmacy Faculty Assembly Appreciation Award, 1995-96
Speaking Honors from Prescribing Psychologists' Register
presented in Marina Del Rey, 1996
Co-preceptor of the Year Award
Presented by USC fourth-level Pharm.D. class, 1991-92
Nebraska Society of Hospital Pharmacists' Outstanding Student
Member Award, 1988
Academy of Students of Pharmacy Chapter Achievement
Award/Scholarship, 1986 - 87
Third Place Award/Scholarship in the Patient Counseling
Competition sponsored by the Academy of Students of
Pharmacy - 1986 -1987
JOURNAL REVIEWER
Journal of Neuropsychopharmacology
Primary Care Companion to Journal of Clinical Psychiatry
Clinical Therapeutics
Pharmacotherapy
American Journal of Health-System Pharmacists
Journal of Pharmacy Practice
The Journal of the American Pharmacists Association
Lexicomp Inc.
10
The Rx Consultant
AREAS OF RESEARCH INTEREST
Psychiatric Pharmacy Practice
Clinical Psychopharmacology
Child and Adolescent Psychopharmacology
Rational Use of Psychotropics in the Medically-Ill
Bibliography
Julie Ann Dopheide
PUBLICATIONS IN REFEREED JOURNALS
D Khorsandi P, Dopheide JA. “Psychiatric Pharmacist Management of Depression in
Patients with Diabetes (letter). Prim Care Compan CNS Disord. 2013;15(5):4088-89.
Dopheide, JA. “Using Antipsychotics Appropriately and Safely”. Issue in Rx
Consultant, July 2013.
Dopheide, JA. Recognizing and Referring At-Risk Youth. Ment Health Clin.
2013;2(11):100. Available at: http://cpnp.org/resource/mhc/2013/05/recognizing-and-
referring-risk-youth. Accessed May 15, 2013.
Dopheide, JA. Vilazodone’s comparative merits have yet to be demonstrated
(editorial). Am J Health-System Pharmacists. 2012;69(18): 1549.
Dopheide JA, Stimmel GL. Depression Treatment: More Ups than Downs
Rx Consultant June 2012 Volume 21(8):1-8. www.rxconsultant.com
Chung, B, Dopheide JA, Gregerson P. Psychiatric pharmacist and primary care
collaboration at a skid-row safety net clinic. Journal of the National Medical
Association 2011; J Natl Med Assoc. 2011;103:567-574
Wang I, Dopheide JA, Gregerson P. The role of a psychiatric pharmacist in a skid-
row safety net clinic in Los Angeles. Journal of Urban Health online pub April 2011
Published in hardcopy journal August 2011;88(4): 718-723.
Dopheide JA. Iloperidone: does it have any meaningful place in therapy?
Am J Health System Pharmacist 2011;68:297 (editorial).
11
Dopheide JA, ADHD an Update: Continuing education for Pharmacists, for
publication in Rx consultant, April 2010 Volume 19(4):1-8. www.rxconsultant.com
Dopheide JA, Pliszka SR Attention-deficit Hyperactivity Disorder: An Update
Pharmacotherapy 2009;29(6):656-679.
Dopheide JA. The role of Pharmacotherapy and Managed Care Pharmacy
Interventions in the Treatment of ADHD. Am J Managed Care 2009;S141-S150.
Dopheide JA, Stimmel GL. Depression: treating to recovery
Rx Consultant published September 2008 Volume 17(8):1-8. www.rxconsultant.com
Dopheide JA. Paliperidone: just a metabolite of risperidone? (editorial). Am J
Health-System Pharmacy 2008;65:401.
Newcorn JH, Dopheide JA, Gray CL. Advances in the Management of ADHD: An
Evidence-Based Update for Managed Care. Managed Care Consultant. July
2007;6(2):1-32 www.mcconsultant.com
Gable KN, Dopheide JA. Eating Disorders: An Update on Recognition, Diagnosis
and Treatment. Rx Consultant published June 2007;16(6):1-8. www.rxconsultant.com
Knox ED, Dopheide JA, Wincor MZ, Han PA. Depression Screening in a University
Campus Pharmacy: A Pilot Project. J Am Pharm Assoc 2006;46:502-506
July/August 2006.
Dopheide, JA. Recognizing and treating depression in children and adolescents:
clinical review. AJHP 2006;63:233-43
Cheng CM, Louis AS., Dopheide JA (guest editor). Insomnia The Rx Consultant,
2006;15:6.
Gable KN, Dopheide JA. Psychotropic Medication Use at a Private Eating Disorders
Treatment Facility: a Retrospective Chart review and Descriptive Analysis. Current
Therapeutic Research. 2005;66(6): 572-588.
Dopheide JA. Therapeutic Position Statement on ADHD. American Society of Health
System Pharmacists. Am J of Health-System Pharm. 2005;62:2-18.
Dopheide JA. Bipolar Disorder: Managing the Ups and Downs of a Complex Illness
The Rx Consultant, March 2005;14(3):1-12. www.rxconsultant.com
Dopheide JA. Attention Deficit Hyperactivity Disorder. Rx Consultant
May 2003;10(5):1-8. Continuing Education Network Inc.
12
Park SH, Dopheide JA, Gill MA. Visual compatibility of risperidone solution and
lithium citrate syrup (letter). Am J Health System Pharmacy 2003;60(6):612-613.
Roe KK, Dopheide JA, Wincor MZ. "Developing a partnership between psychiatric
pharmacists and NAMI". Schizophrenia Bulletin 2002;28(3):525-529.
Dopheide JA, Park S. Special Report on Anxiety Disorders: Psychopharmacology of
Anxiety. Psychiatric Times, March 2002.
Dopheide JA. Management of Depression in Children and Adolescents
Journal of Pharmacy Practice 2001;14(6):488-497.
Stimmel GL, Dopheide JA. Sleep Disorders: Focus on Insomnia
US Pharmacist 2000;67-79
Elhaj, Bernard, Dopheide JA, Gill MA. Migraine Headaches. Pharmacy Times
2000;66(1):59-75.
Lima WJ, Dopheide JA, Kramer BA, Earhart CA, Wincor MZ. A naturalistic
comparison of slow-titration vs. loading divalproex sodium in psychiatric inpatients.
J Affective Disorders 1999;52:261-267.
Dopheide JA, Wincor MZ. Gabapentin and lamotrigine in the treatment of bipolar
disorder. J Am Pharmaceutical Association 1998;38(5):632-4.
Stimmel GL, Dopheide JA, Stahl SM. Mirtazapine: A Noradrenergic antidepressant
with specific serotonergic effects. Pharmacotherapy 1997;17(1):10-21
Stimmel GL, Dopheide JA. Psychotropic drug-induced reductions in seizure
threshold: Incidence and consequences. CNS Drugs January 1996; 5(1):37-50
MANUSCRIPTS IN PROGRESS
None
PUBLICATIONS IN NON-REFEREED JOURNALS
Dopheide JA. “The Management of Depression and Anxiety in the Long-term care Patient”.
Power-pak CE. www.powerpak.com. March 2007.
Dopheide JA. “A Calming Influence: An Analysis of ADHD Treatments.
Pharmacy times CE program, published August 2006.
Dopheide JA, Kushida CA. Newer Options in the Management of Insomnia.
U.S. Pharmacist and powerpak.com, published October 2005.
13
Dopheide JA, Stimmel GL. Bipolar Disorder: Optimizing Medications and Patient
Counseling. U.S. Pharmacist and powerpak.com, published September 2005
Dopheide JA. Hot Topics in Pediatric Psychiatry: ADHD and Depression.
California Journal of Health-System Pharmacy 2004;16(3):5-12.
Dopheide JA, Marken PA. Use of Stimulant Medications for Attention-Deficit/Hyperactivity
Disorder Pharmacy Today: Topics in Patient Care, APhA publication, July 2003
Yadegar Shadi, Dopheide JA, Gill MA. The Treatment of Attention Deficit
Hyperactivity Disorder in children. California Pharmacist Summer 2001;55-63.
Dopheide JA, Park S. An update on the pharmacotherapy of anxiety disorders.
California Journal of Health-System Pharmacy 2001;13(1):5-13.
Dopheide, JA. Recognizing and treating depressive disorders. Women's Health Care
Supplement, Drug Topics May 1995
Dopheide JA, Stimmel GL, Yi DD. Focus on Nefazodone: a serotonergic drug for
major depression. Hospital Formulary - April, 1995;30:205-212
Puzantian T, Dopheide JA. Major depression in patients with HIV infection and
AIDS: Epidemiology and therapeutic outcome of antidepressant treatment. California
Pharmacist, February 1995;2:27-32.
Gutierrez MA, Dopheide JA. A residency program in psychopharmacy
California Journal of Hospital Pharmacy, February 1990;2:13-14
BOOKS AND CHAPTERS IN BOOKS
Dopheide JA, Stimmel GL. Sleep Disorders: Chapter in Applied Therapeutics, Tenth
Edition, Edited by Young L, Koda-Kimble MA (eds), published by Lippincott,
Williams and Wilkins, Philadelphia, PA, copyright 2013.
Dopheide JA. Pliszka, SP. “Psychiatric Disorders of Childhood”,
chapter in Pharmacotherapy: A Pathophysiological Approach: Eighth Edition, Edited
by Dipiro and Wells, Published by McGraw-Hill, copyright 2011.
Dopheide, JA. Drug-induced Anxiety. Chapter in “Drug-induced diseases:
prevention, detection, and management”. American Society of Health-System
Pharmacists, Bethesda, Maryland. copyright 2010.
Dopheide JA, Stimmel GL. Sleep Disorders: Chapter in Applied Therapeutics, Ninth
Edition, Edited by Young L, Koda-Kimble MA (eds), published by Lippincott,
14
Williams and Wilkins, Philadelphia, PA copyright 2009.
Dopheide JA. Tran-Tesoro JH, Malkin M. “Psychiatric Disorders of Childhood”,
chapter in Pharmacotherapy: A Pathophysiological Approach: Seventh Edition, Edited
by Dipiro and Wells, Published by McGraw-Hill. copyright 2008.
Dopheide JA. “Medication Issues”, chapter in Obstructive Sleep Apnea Textbook,
edited by Clete Kushida, M.D. Informa Healthcare USA, NY, NY copyright: 2007
Dopheide, JA. Drug-induced Anxiety. Chapter in “Drug-induced diseases:
prevention, detection, and management”. American Society of Health-System
Pharmacists, Bethesda, Maryland. copyright 2005.
Dopheide JA, Theesen KA, Malkin M. Psychiatric disorders of childhood and
treatment. In Pharmacotherapy: A Pathophysiologic Approach: Sixth Edition,
Edited by DiPiro, Published by Mc-Graw Hill, copyright 2005.
Dopheide JA, Stimmel GL. Sleep Disorders: Chapter in Applied Therapeutics,
Eighth Edition, Edited by Young L, Koda-Kimble MA (eds), published by Lippincott,
Williams and Wilkins, Philadelphia, PA , copyright 2004.
Dopheide JA. Psychiatric Pharmacy Specialty Practice. In: Encyclopedia of Clinical
Pharmacy. First Edition, Edited by DiPiro, Published by Marcel Dekker Inc. New
York, NY. copyright, 2003.
Dopheide JA, Theesen KA. Psychiatric disorders of childhood and treatment. In
Pharmacotherapy: A Pathophysiologic Approach: Fifth Edition, Edited by DiPiro,
Published by Appleton and Lange,: Spring, 2002.
Dopheide JA, Stimmel GL. Sleep Disorders: Chapter in Applied Therapeutics,
Seventh Edition, Edited by Young L, Koda-Kimble MA (eds), published by
Lippincott, Williams and Wilkins, Philadelphia, PA , 2001.
Dopheide JA, Theesen KA. Psychiatric disorders of childhood and treatment; In
Pharmacotherapy: A Pathophysiologic Approach: Fourth Edition, Edited by DiPiro,
Published by Appleton & Lange 1999.
Dopheide JA. Sleep Disorders: Chapter in Applied Therapeutics, Sixth Edition,
Edited by Young L, Koda-Kimble MA (eds), published by Williams & Wilkins,
Vancouver, Washington, 1995.
Theesen KA, Dopheide JA. Psychiatric disorders of childhood and treatment In
Pharmacotherapy: A Pathophysiological Approach, Third Edition, edited by DiPiro,
published by Appleton & Lange, 1996.
15
Dopheide, JA. Antiparkinson Adverse Effects/Management In Psychotopic
Medications Desktop Reference. Tornatore FL, Sramek JJ Eds. PsychMed Manisses
Communications, Providence RI, copyright July 1996.
Cabrera J, Dopheide JA, Holland SA. Psychopharmacology for nurses - 1st edition,
Los Angeles County School of Nursing, copyright August, 1993.
CHAPTERS IN PROGRESS
Dopheide JA. Pliszka, SP. “Attention-deficit Hyperactivity Disorder”, chapter in
Pharmacotherapy: A Pathophysiological Approach: Ninth Edition, Edited
by Dipiro and Wells, Published by McGraw-Hill. Expected publication in 2014.
Dopheide JA. “Autism Spectrum Disorder” chapter in Advanced Pediatric
Pharmacotherapy, published by the Pediatric Pharmacy Advocacy Group, Editors:
Hooper and Eiland. Expected publication in Spring of 2014.
EDUCATIONAL WEBINARS/Online Continuing Education
Dopheide JA. Attention Deficit Hyperactivity Disorder (ADHD) Email Case Study Series. Developed by American Pharmacists Association. Sent to 60,000 members nationally. March/April 2012 and available on www.pharmacist.com
Dopheide JA. ADHD Diagnosis: A Detective’s Job
http://www.medscape.com/viewarticle/740679
Medscape Medical News Interview
April 13, 2011
“Update on the Treatment of ADHD: Improving Outcomes”
Online Continuing Education for the College of Psychiatric and Neurologic Pharmacists
(CPNP). Creative Educational Concepts www.ceconcepts.net/adhd
September 2008 – December 2009
“Insights on Insomnia for Pharmacists” www.sleepmeded.org
Sleep Medicine Educational Foundation (SMEI)
New York, NY, November 2007
EDUCATIONAL PUBLICATIONS
ADHD Drug Therapy Monograph Updates
Lexicomp Inc. Spring 2012
Getting to Goal for ADHD: New Strategies for the Continuum of Patients with ADHD
Published by Ascend Media. January 2009.
16
“Methylphenidate/Dexmethylphenidate” consumer publication on NAMI website; nami.org
Fall 2007
“Ask the Psychiatric Pharmacist”, 2 educational publications on NAMI website; nami.org
Spring, 2006.
Insomnia Update, Continuing Education Program for Pharmacists
Produced by CE Solutions and supported by Takeda Pharmaceuticals
February 2006
Management of ADHD: continuing education publication for pharmacists produced by Bimark
Medical Communications and supported by Novartis Pharmaceuticals
August 2005
ADHD: Current Concepts in Diagnosis and Behavioral Interventions
Continuing education internet program for Medscape communications
April 2001
Concerta Product Monograph, Expert Panelist
American Pharmaceutical Association
January 2001
Expert Consensus Guideline Development for Treatment of Schizophrenia
One of 60 participants nationally, for publication in 2003.
American Society of Health System Pharmacists Board Preparatory Manual
"PharmPrep" Reviewer for First Edition, in development for 2001, update 2003
Mood Disorders
Sleep Disorders
Anxiety Disorders
Substance Abuse
Glaucoma
American Society of Health System Pharmacists Board of Pharmaceutical Specialties
Review Course Manual: Pediatric Issues in Psychiatry, Sleep Disorders.
March 2000, March 2001, March 2002, May 2003
American Pharmaceutical Association (APhA's) Guidebook for Psychiatric Disease
State Management - one of six panelists responsible for development of the following
guides:
Management of Major Depression
Management of Acute Mania of Bipolar Disorder
Management of Acute Depression of Bipolar Disorder
Published 12-96 by APhA
Management of Obsessive Compulsive Disorder
Management of Panic Disorder
Management of Schizophrenia
17
Published Summer of 1997 by APhA
Management of Generalized Anxiety Disorder
Published Fall of 1998 by APhA
ABSTRACTS OF PAPERS PRESENTED
Khorsandi P, Dopheide JA et al. Psychiatric Pharmacist Management of Depression
in Patients with Diabetes. Presentation at Western States Conference for Pharmacy
Residents and Preceptors, Monterey, California, May 2012
Wang, IL, Dopheide JA, Gregerson P. Role of a pharmacist in a psychiatric
medication management clinic. Presentation at Western States Conference for
Pharmacy Residents and Preceptors, Monterey, California, May 2010.
Chung B, Dopheide JA. Developing a pharmacist-run psychiatry service in a safety
next clinic. Presentation at Western States Conference for Pharmacy Residents and
Preceptors, Monterey, California, May 2009.
Gable KN, Dopheide JA. Psychotropic Medication Use at an Eating Disorders
Treatment Facility. Presentation at Western States Conference for Pharmacy Residents
and Preceptors, Monterey, California, May 2005
Knox ED, Dopheide JA, Han P, Wincor MZ. Depression Screening in a Community
Pharmacy. Presentation at Western States Conference for Pharmacy Residents and
Preceptors, Monterey, California, May 2004
Dopheide, JA.. “Dosing Atypical Antipsychotics in Children and Adolescents”.
Presentation at American Society of Consultant Pharmacists Meeting, Anaheim,
California, November 2002.
Presentation at ASHP’s Midyear Clinical Meeting, Atlanta, Georgia December, 2002.
Presentation at CPNP's Annual Meeting, Charleston, South Carolina, May 2003.
Myong A, Turkel SB, Dopheide JA, Tavare J. Treatment of Depression in Medically-
Ill Children and Adolescents. Presentation at Western States Conference for Pharmacy
Residents and Preceptors, Monterey, California, May 2002.
Park, S, Dopheide, JA, Bolger M. Compatability of risperidone solution with lithium
citrate. Presentation at Western States Conference for Pharmacy Residents and
Preceptors, Monterey, California, May 2001
Roe K, Dopheide JA, Wincor MZ. Developing a partnership between psychiatric
pharmacists and NAMI. Poster presentation at California Society of Health-System
Pharmacists Seminar 2000, Palm Springs, California, October 2000.
18
Roe K, Dopheide JA, Wincor MZ. Developing a partnership between psychiatric
pharmacists and NAMI. Presentation at Western States Conference for Pharmacy
Residents and Preceptors, Monterey, California, May 2000.
Wetzler H, Allen CA, Earhart CA, Dopheide JA. Cognitive level and psychiatric
patients' ability to access their medications: a pilot study. Presentation at Western
States Conference for Pharmacy Residents and Preceptors, Monterey, California, May
1999.
Lima W, Dopheide JA, Kramer B. A prospective single-blind comparison of the
tolerability of traditional vs. loading divalproex sodium (Depakote®) in psychiaric
inpatients. Presentation at Western States Conference for Pharmacy Residents and
Preceptors, Monterey, California, May 1997 and ASHP Midyear Clinical Meeting in
Atlanta, Georgia, December 1997.
Puzantian TP, Dopheide JA. Major Depression in patients with HIV and AIDS:
epidemiology and therapeutic outcome of antidepressant treatment.
Poster presentations at Western States Conference for Pharmacy Residents and
Preceptors, CSHP Seminar ' 94 and ASHP Midyear Clinical Meeting in Monterey,
California, May 1994, San Diego, California, October 1994 and Miami Beach, Florida,
December 1994
Dopheide JD, Gabaldon NG, Botello T. The incidence and prevention of constipation
in psychiatric inpatients: a preliminary study. Platform presentation at the Western
States Conference for Pharmacy Residents and Preceptors. Monterey, California, 1992
Schneider LS, Pawlucek S, Dopheide JA, Lyness SA. Nortriptyine and
hydroxymetabolite pharmacokinetics in Asian vs Caucasian volunteers - a pilot study.
Poster presentation at the American Psychiatric Association Annual Meeting, New
Orleans, Louisiana, 1991.
Schneider LS, Dopheide JA, Suckow RD, Sloane RB. Nortriptyline and
hydroxymetabolite kinetics in younger vs older adults - pilot study. Poster presented at
the American Psychiatric Association Annual Meeting New York, New York, May
1990.
Dopheide JA, Schneider, Gleason, RS, Sloane RB. Nortriptyline and
hydroxymetabolite kinetics in younger vs older adults - research in progress. Paper
presented at Western States Conference for Residents and Preceptors Monterey,
California, April 1989.
Dopheide JA, Wincor MZ, Gross LS. L-tryptophan as an adjunct to tranylcypromine
in the treatment of chronic atypical depression: case report and literature review.
Paper presented at the California Society of Hospital Pharmacists Seminar '88,
Anaheim, California, October 1988.
19
INVITED CONFERENCE PRESENTATIONS
Pediatric Mental Health: Minding Medication Matters
36th
Annual Arthur E. Schwarting Symposium
University of Connecticut, Storrs campus
May 2013
Comprehensive Medication Management Pearl
College of Psychiatric and Neurologic Pharmacists Annual Meeting
Colorado Springs, CO
April 2013
Pulling Back the Covers on Insomnia
American Pharmacists Association Annual Meeting
Los Angeles, CA
March 2013
Troubled Teen 101: Topics in Adolescent Psychiatry
American Society of Health System Pharmacists Midyear Clinical Meeting
Las Vegas, NV
December 2012
Antipsychotics for the Non-Psychiatric Pharmacist: Across the Ages
American Society of Health-System Pharmacists Midyear Clinical Meeting
Las Vegas, NV
December 2012
Adolescent Psychiatry: Troubled Teen 101
Presented at USC Board of Counselors Winter Retreat
Ojai, California
January 2012
Schizophrenia, Depression, Bipolar Disorder, Autism, Pediatric Psychiatry
Presented at USC’s Postgraduate Refresher Course
Maui, Hawaii
August 2011
Addressing Challenging Situations in the Management of ADHD
Presented at the American Pharmacists Association Annual Meeting
Seattle, Washington
March 2011
Autism Spectrum Disorders
Presented at the American Pharmacists Association Annual Meeting
Washington DC
20
March 2010
The Biggest Loser: a Pill to Manage Antipsychotic-Induced Weight Gain? (clinical pearl)
Presentation at the American Society of Health System Pharmacist’s Annual Meeting
Las Vegas, NV
December 2009
Strategies and Controversies in the Management of ADHD
Presented at the American College of Clinical Pharmacy’s Annual Meeting
Anaheim, CA
November 2009
ADHD: An Update
Presented at California Society of Health-System Pharmacists Seminar 2009
San Diego, CA
October 2009
Insomnia: A Ubiquitous and Elusive Disorder and
Antidepressants and Suicide Risk
Presented at the Practical Use of Psychotropics Regional Meeting
Billings, MT
May 2009
Antidepressants and Suicide Risk: Using the Evidence to Separate Fact from Fiction
Presented at the College of Psychiatric and Neurologic Pharmacists Annual meeting
Jacksonville, FL
April 2009
Safe and Coordinated Care of Psychiatric Disorders: Bipolar Disorder and Schizophrenia
Presented at APhA’s Annual Meeting
San Antonio, TX
April 2009
“Got Prozac?” Managing depression in primary care
Presented at the Community Clinics Association of Los Angeles
Anaheim, CA
January 2009
Review of Major Depression and Treatment Outcomes in Children and Adolescents
Presented at ASHP’s Midyear Clinical Meeting
Orlando, Florida
December 2008
Getting to Goal with ADHD: New Strategies for the Continuum of Care for ADHD.
Presented at the American Osteopathic Association’s Annual Meeting
Las Vegas, NV
October 2008
21
Anxiety Disorders in Youth
presented at the College of Psychiatric and Neurologic Pharmacists Meeting
Phoenix, AZ
April 2008
The Appropriate Treatment and Management of ADHD
presented at the American Pharmaceutical Association’s (APhA) Annual Meeting
San Diego, CA
March 2008
Reimbursement for Community Psychiatric Pharmacist Services: Advances and
Limitations in the U.S.
presented at the 2nd
Annual British Columbia Psychopharmacology Conference
Vancouver, British Columbia, Canada
February 2008
Pharmacists How to UtilizeYour Pharmacist for Better Health in the Hospital and at Home
presented at the NAMI (National Alliance for Mentally Ill) National Meeting
San Diego, CA
June 2007
Black Box Warnings: What do they mean for the consumer? (development/moderator)
presented at the NAMI (National Alliance for Mentally Ill) National Meeting
San Diego, CA
June 2007
Advances in Sleep Medicine (moderator of 3 hr recertification program)
presented at the College of Psychiatric and Neurologic Pharmacists Annual Meeting
Colorado Springs, CO
April 2007
Managing Depression in the Cancer Patient
presented at the Scripps Advanced Practice Oncology Nursing Conference
Coronado, CA
March 2007
A Med Guide to Prevent Youth Suicide? (clinical pearl)
presented at the Midyear Clinical Meeting of ASHP
Anaheim, CA
December 2006
New Treatment Options for Insomnia
presented at the Midyear Clinical Meeting of ASHP
Las Vegas, NV
December 2005
22
New Developments in the Treatment of ADHD: an Interactive Discussion
presented at the T.D. Rowe Pharmacy Lectures
Ann Arbor, MI
October 2005
The Pharmacists role in Managing and Counseling Patients with Bipolar Disorder
presented at the American Pharmacists Association Annual Meeting.
Orlando, Florida
April 2005
ADHD and Bipolar Disorder: Current Issues
presented at the College of Psychiatric and Neurologic Pharmacists Annual Meeting
San Diego, California
March 2005
Suicidality and Antidepressants
presented at the Child Courts Mental Health Conference, LA Convention Center
October 2004
Los Angeles, California Safe and Effective Use of Antidepressants in Youth
presented at the 8th annual Northeastern Psychiatric Pharmacotherapy Update
Sturbridge, Massachussets
September 2004
Current Issues in the Treatment of ADHD
presented at the 151st Annual Meeting of the American Pharmaceutical Association
Seattle, Washington
March 2004
Special Considerations for Managing Depression in the Cancer Patient
presented at the Scripps Cancer Center's Oncology Advanced Practice Conference
Mission Valley San Diego, California
February 2004
Sleep Disorders
presented at the Psychiatric Pharmacy Practice Specialty Examination Review Course
sponsored by the American Society of Health-System Pharmacists
Washington, D.C. April 2000
Denver, Colorado March/April 2001
Seattle, Washington April 2002
Charleston, South Carolina May 2003
Chicago, Illinois April 2004
San Diego, California, March 2005
Baltimore, Maryland, April 2006
Colorado Springs, Colorado, April 2007
Pediatric Issues in Psychiatry
23
presented at the Psychiatric Pharmacy Practice Specialty Examination Review Course
sponsored by the American Society of Health-System Pharmacists
Washington, D.C. April 2000
Denver, Colorado March/April 2001
Seattle, Washington April 2002
Charleston, South Carolina May 2003
Chicago, Illinois April 2004
San Diego, California March 2005
Baltimore, Maryland, April 2006
Colorado Springs, Colorado, 2007
"Bipolar Disorder: Therapeutic Update"
presented at the California Pharmacists Association Annual meeting
Anaheim, California
March 2003
"The Use of Antidepressants in Children and Adolescents"
presented at the California Pharmacists Association Annual meeting
Anaheim, California
March 2003
“Immunomodulation in Neurology and Psychiatry: Focus on Mood Disorders
presented at the American Society of Health-System Pharmacists Midyear meeting
Atlanta, Georgia
December 2002
“Focusing Attention on ADHD”
presented at the California Society of Health-System Pharmacists
Anaheim, California
October 2002
“Lithium and Anticonvulsants for Bipolar Disorder
presented at the Idaho Society for Health-System Pharmacists
Sun Valley, Idaho
September 2002
“Child and Adolescent Psychopharmacology”
presented at the Idaho Society for Health-System Pharmacists
Sun Valley, Idaho
September 2002
“The Weighty Issues in Comparing Atypical Antipsychotics”
presented at the University of Southern California’s
45th
Annual Post-graduate Refresher Course
Maui, Hawaii
August 2002
24
“Depression and Treatment in the 21st Century”
presented at the University of Southern California’s
45th
Annual Post-graduate Refresher Course
Maui, Hawaii
August 2002
“My Antipanic Medication is Giving me Panic Attacks”
Presented at ASHP’s Midyear Clinical Meeting Clinical Pearls Program
New Orleans, Louisiana
December 2001
ADHD: Breaking Issues in Diagnosis and Treatment
Presented at the American Society of Health-System Pharmacists Annual Meeting
Los Angeles, California
June 2001
ADHD: Current Concepts in Diagnosis and Behavioral Interventions
Presented at the American Pharmaceutical Association’s Annual Meeting
San Francisco, California
March 2001
Attention to the Impact of Diagnosis and Treatment of ADHD
presented at the California Society of Health-System Pharmacists Focus 2000
Oakland, California
March 2000
Newer Psychotropics in Adolescents
presented at the American Society of Health-System Pharmacists Midyear Clinical Meeting
Orlando, Florida
December 1999
Neuropsychiatric Disorders in the Elderly: Managing Sleep Disorders
presented at the American Society of Health-System Pharmacists Home Care Meeting,
Chicago, Illinois
August 1999
Advances and Controversies in the Management of Sleepiness and Insomnia: Clinical Cases
presented at the American Society of Health-System Pharmacists Annual Meeting
June 1999
Contemporary Issues in Child/Adolescent Psychopharmacology
presented at the California Quality Improvement (CALQUIC) Conference, Napa, CA
March 1999
Pharmacodynamic Interactions with Mood Stabilizers: Clinical Pearl Platform Presentation
American Society of Health-System Pharmacists MCM Meeting, Las Vegas, NV
December 1998
25
Advances in the Treatment of Mood Disorders Part I: New Mood Stabilizers
Presentation at First Annual Psychiatric Pharmacotherapy Update, Pasadena, CA
September 1998
Special Patient Populations and Data Driven Algorithmic Approaches to Patient
Management: Advances In Treating Depression in Primary Care - Achieving Patient
Wellness. Symposium at the American Society of Health-System Pharmacists' Midyear
Clinical Meeting. Atlanta, Georgia, December 1997.
Issues in the Pharmacological Management of ADHD - A Case-Based Presentation
California Society of Health-System Pharmacists, Seminar '97, October 1997
Opportunites for Pharmaceutical Care Interventions Using APhA's Psychiatric Drug
Treatment Protocols APhA Annual Meeting, Los Angeles Convention Center, Los
Angeles, California
March 1997
Issues in the Pharmacological Management of ADHD presentation at the Third Annual
Western Regional Psychopharmacy Update On Contemporary Issues in Psychiatry for
Pharmacists
Santa Clara, California - October 1996
In-Depth Long Term Management of Patients in a Psychopharmacy Clinic presented at
Great-Lakes Regional Psychopharmacy Update, Toledo, Ohio - June 1996.
Psychiatric Disorders in Medically-Ill Patients - Introduction, Moderator
Presented at The American Society of Health-System Pharmacists Midyear Clinical
Meeting, Las Vegas, Nevada - December 1995
A Clinical Comparison of Antidepressants presented at CNS: New Frontiers
Chairperson, Introduction, Moderator , California Society of Health-System
Pharmacists Seminar '95, Palm Springs, California - October 1995
Experience with Risperdal: A Clinical Comparison of Typical and Atypical
Antipsychotics presented at the California Society of Health-System Pharmacists
Seminar '95, Palm Springs, California - October 1995.
Mood Disorders - Management of Depression, Mood Disorders - Management of
Bipolar Illness, Treatment of Child and Adolescent Psychiatric Disorders,Care of Sleep
Disorders and Counseling Patients on Psychotropic Drugs all presented at Drug
Therapy and Pharmacy Practice for the 21st Century, 38th Annual Postgraduate
refresher course in Hawaii
University of Southern California School of Pharmacy, Ritz-Carlton, Maui, Hawaii -
August 1995.
26
Depression in Late Life: A Clinical Comparison of Antidepressants at the Geriatric
Pharmacy Mini-Residency Program: Therapeutic Assessment and Implementation
sponsored by California Geriatric Education Center. Huntington Memorial Medical
Center, Pasadena, California - June 1995
Clinically Significant Differences in Antidepressants & Counseling the Patient with
Major Depression- case discussion . Continuing Education Seminar for pharmacists
sponsored by
USC School of Pharmacy and Wyeth Pharmaceuticals Los Angeles, California
September 1994.
Rational Use of Psychotropics in the Medically Ill, Continuing Education Platform
Presentation for the California Society of Hospital Pharmacists Seminar '92 in
Anahiem, California - October 1992.
L-Tryptophan as an Adjunct to Tranylcypromine in the Treatment of Chronic Atypical
Depression: A Case Report and Literature Review, California Society of Hospital
Pharmacists Seminar '88, Anaheim, California - October 1988
INVITED LECTURES
Optimizing Depression Care from Admission through Discharge: Pharmacists role in
MTM, CDTM and CMM. Lecture presented to Pharmacy Learning Network (PLN)
continuing education program for pharmacists
March 2013 – Orlando
April 2013 – Chicago
May 2013 - Newark
“A Case of Delirium in a 10 year old” grand rounds presentation
for LAC+USC Department of Psychiatry, Child/Adolescent Division
January 2009
Hot Topics in Child and Adolescent Psychiatry
Presented at the Child/Adolescent Didactic Conference
LAC+USC Department of Child and Adolescent Psychiatry
November 2006
Safe and Effective Use of Antidepressants in Youth
presented at the Child/Adolescent Didactic Conference
LAC+USC Department of Child and Adolescent Psychiatry
October 2005
Treating Psychiatric Disorders in Children and Adolescents
presented at the 18th
Annual USC Las Vegas Seminar
March 2005
27
Treating Eating Disorders in Children and Adolescents
presented at the 18th
Annual USC Las Vegas Seminar
March 2005
Women and Migraine
presented at USC's postgraduate refresher course
Maui, Hawaii
August 2003
Child and Adolescent Psychopharmacology
presented at USC's postgraduate refresher course
Maui, Hawaii
August 2003
Overview of Psychotropics: Focus on Newer Medications
presented to East San Gabriel Valley Alliance for the Mentally Ill (ESGV AMI)
April 2003, November 2005, 2006
Child and Adolescent Psychopharmacology
presented to the Department of Psychology
LAC+USC Medical Center
April 2003
Special Considerations for Using Atypical Antipsychotics in Children and Adolescents
presented to Department of Child & Adolescent Psychiatry
LAC+USC Medical Center
January 2003
A Clinical Comparison of Atypical Antipsychotics: Continuing Education program
presented to USC Alumni and Preceptors
USC School of Pharmacy
October 2002
Treating Depression in Women On and Off HRT
presented to Obstetrics and Gynecology medical departmen of
Kaiser Permanente Medical Center, Panorama City, California
August 2002
Update on Medications for Mental Health
presented to East San Gabriel Valley NAMI chapter, Los Angeles, California
November 2000
Child/Adolescent Psychopharmacology
presented at LAC Courthouse 95a, Los Angeles, California
October 2000
28
Pharmacokinetics and Pharmacodynamics of the Psychotropics
presented in Psychopharmacology Series for Third Year Residents, LAC+USC
Los Angeles, California
July 2000
Benzodiazepine Withdrawal: "A Mind-blowing experience"
presented at LAC+USC Department of Psychiatry Grand Rounds
Los Angeles, California
June 2000
Antidepressants in Children and Adolescents: Focus on SSRIs
presented for Clinical Case Conference- Department of Child/Adolescent Psychiatry- USC
Los Angeles, California
May 2000
Child/Adolescent Psychopharmacology Lecture Series
presented to Psychology Department, USC School of Medicine
Los Angeles, California
April - May 2000
An Overview of Psychotropics: Focus on Newer Agents
presented to San Gabriel Valley NAMI Chapter
Pasadena, California
May 2000
Psychiatry Review
presented to USC Pharmacy School Graduates
Los Angeles, California
May 2000
Child/Adolescent Psychopharmacology/ Substance Abuse
presented to Prescribing Psychologists' Register - Series 7, Miami, Florida
April 2000
An Overview of Psychotropics: Focus on Newer Agents
presented to Long Beach NAMI Chapter
Long Beach, California
February 2000
Special Considerations for Using Antipsychotics in Youth
presented for Didactic Clinical Case Conference- Department of Child/Adolescent
Psychiatry, Los Angeles, California
January 2000
Pharmacodynamics and Pharmacokinetics of Psychotropics
presented to Cedars-Sinai Psychiatry Residents
January 2000
29
Child/Adolescent Psychopharmacology
presented to Prescribing Psychologists' Register - Series 6, Miami, Florida
January 2000
Anxiety Disorders and Treatment
presented to Prescribing Psychologists' Register - Series 5, Miami, Florida
October 1999
Antidepressants in Psychiatry: An Update for Clinicians
presented for Psychiatry Grand Rounds at Kaiser Permanente Medical Center, Fontana, CA
July 1999
New Drugs in Psychiatry
presented to East San Gabriel Valley Alliance for the Mentally Ill Chapter, La Puente, CA
July 1999
Child/Adolescent Psychopharmacology
presented to Prescribing Psychologists' Register - Series 6, Austin, Texas
July 1999.
Anxiety Disorders and Treatment
presented to Prescribing Psychologists' Register - Series 5, Austin, Texas,
April 1999
Child/Adolescent Psychopharmacology/Practical Psychopharmacology of Substance Abuse
presented to Prescribing Psychologists' Register - Series 6, Oklahoma City, OK
January 1999
Care of Sleep Disorders
presented to Prescribing Psychologists' Register - Series 5, Manchester, NH
December 1998
Clinical Comparison of Atypical Antipsychotics
presented to Pharmacy and Medical staff at King-Drew Medical Center, Los Angeles, CA
November 1998
Drug Selection In Psychiatry - Case Studies
USC Department of Psychiatry PGY1 & 2 Lecture Series , August 1998, October 1998
Treatment of Mood Disorders
USC Medical School's Neurobehavior Series - Level II, December 1997 - 2000
Treatment of Psychiatric Disorders in Childhood and Adolescence
USC Physician's Assistant Curriculum - November 1997
Obesity: How to Manage This Chronic Disorder, The Use of Appetite Suppressants.
30
USC Continuing Education Program, October 12, 1997
So Many Antidepressants, So Few Choices
Continuing Education program sponsored by USC School of Medicine
Century City Hospital, Century City, California, September , 1997
Child and Adolescent Psychiatric Disorders: Clinical Characteristics and Pharmacological
Management . Workshop for Pharmacists, Las Vegas, Nevada, September 1997
Clinical Pharmacy Lecture Series Focusing on Psychiatric Pharmacy Practice
presented to Tokyo University Pharmacy and Life Sciences (TUPLS) - 26 hours
Tokyo, Japan - June/July 1997
Child/Adolescent Psychopharmacology Update
presented to International Conference of Prescribing Psychologists'
Las Vegas, Nevada - June 1997
Psychotropic Medications and Quality of Life presentation for Lanterman Developmental
Center and Social Work Professional Group, Pomona, California - May 1997
Clinical Considerations for Using Psychotropics in Youth presentation to pharmacy staff
at Metropolitan State Hospital, Norwalk, California - April 1997
Psychopharmacology Review presented 9 hours for Prescribing Psychologists' Register
Marina del Rey, California, New York, New York - September 1996, January 1997,
March 1997, September 1997, March 1998
Psychopharmacology in Children and Adolescents presented 5 hours for Prescribing
Psychologists' Register, Marina del Rey, California, May and September 1996.
Using Psychotropic Medications in Younger Age Groups Los Angeles County
McClaren Hall Youth Residential Center El Monte, California - May 1995
Overview of Psychotropics focusing on New Agents and Clinical Implications -
presented to East San Gabriel Valley Alliance for the Mentally Ill (ESGVAMI)
Puente, California , April 1995
Medication Compliance in Psychiatric Patients. Educational Seminar presented to
LAC/USC Social Work Department Los Angeles, California - September 1994.
Mood Stabilizers in Psychiatry: A Clinical Comparison of Lithium, Carbamazepine &
Valproate sponsored by Ciba-Geigy Pharmaceuticals . Educational Seminar presented
to pharmacy and medical staff at Fairview Developmental Center Costa Mesa,
California - May 1994.
Overview of Psychotropics. Educational Seminar presented to the Public Defenders
of Courtroom 99 Los Angeles County Court, Los Angeles, California - January 1993.
31
Psychopharmacology for Clinical Practitioners. Educational Seminar for Psychologist,
Social Workers and other Health Care Professionals affiliated with the American Red
Cross, Los Angeles, California - December 1992.
Medication Management in Residential Psychiatric Facilities. Educational Seminar for
Community Mental Health Workers. Brotman Medical Center, Culver City, California
November 1992
New Pharmacotherapeutic agents. First-year Psychiatry residents lecture series (1
hour) University of Southern California Department of Psychiatry Los Angeles,
California. September 1991 - 1992
Pharmacodynamics and Pharmacokinetics of the Psychotropics
First-year Psychiatry residents lecture series (3 hours) biannually
University of Southern California Department of Psychiatry
Los Angeles, California - January 1991 to present.
Overview of Psychotropics with Nursing Considerations
Seminar to nursing students and nursing staff from East LA School of Nursing and
LAC Nursing staff, LAC/USC Medical Center, Los Angeles, California
January 1991 – present (intermittently presented)
Psychiatric Considerations of Cardiac Drugs
Consultation and Liaison Service, University of Southern California Department of
Psychiatry Los Angeles, California - March 1989
updated: 05-16-13